About Alan Cui
Alan Cui is a Melbourne-based solo angel investor whose primary role is Managing Partner at Boson Ventures. With a physics training background and operator experience as a former founder, his investment lens is oriented toward technically deep companies, particularly in deep tech, biotech, and medical devices across the Asia-Pacific region. His healthcare-relevant deployments emphasize biotech and MedTech opportunities that combine scientific complexity with commercial scaling potential, often at the intersection of advanced materials, hardware, and biological applications.
Cui invests at pre-seed and seed stages, with check sizes typically in the $25,000 to $100,000 range. Geographic activity is concentrated in Australia, with extension into the broader Asia-Pacific region as portfolio companies expand. Deal flow is sourced through Boson Ventures’ network and his connections within the Australian deep tech ecosystem. Investments tend to involve technically differentiated companies emerging from university research environments or operator-led teams pursuing complex scientific or engineering challenges. He typically acts as a participating angel rather than a lead in syndicated early rounds.
For founders, Cui offers a combination of deep technical literacy and operator experience suited to early-stage scientific founders. He is most relevant to biotech and medical device teams pursuing complex hardware, instrumentation, or applied biology platforms, particularly those based in Australia or pursuing APAC market expansion. Engagement is informal, focused on technical advisory and operator perspective on early scaling, recruiting, and product positioning. Founders should expect a relationship oriented around founder support and network access rather than formal governance, and should combine this commitment with institutional capital to round out a credible early-stage syndicate.
Founder reviews
Pitch / review this investor
Have you raised from Alan Cui? Founders only — share your honest experience (anonymous OK, moderated before publishing).